+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market - Global Forecast 2026-2032- Product Image
Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market - Global Forecast 2026-2032- Product Image
Sale

Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market - Global Forecast 2026-2032

  • Report

  • 183 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6139725
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market is projected to reach USD 270.11 Million in 2026. It is expected to continue growing at a CAGR of 10.43%, reaching USD 491.12 Million by 2032.

Introduction to Multiplex Gene Mutation Detection Kits

Human EGFR, KRAS, BRAF, PIK3CA, ALK, and ROS1 mutation detection kits support molecular characterization of tumors and help inform biomarker-guided clinical decision-making. Their relevance is strongest in oncology pathways where treatment selection, resistance assessment, and diagnostic confirmation depend on identifying actionable genomic alterations. Adoption is shaped by analytical performance, specimen quality, workflow integration, regulatory requirements, reimbursement, and access to trained laboratory personnel.

Transformative Shifts in Precision Oncology Diagnostics

The diagnostic landscape is shifting from single-gene testing toward multiplex and sequential testing strategies that improve tissue utilization and broaden biomarker coverage. Laboratories are also balancing tissue-based assays with liquid biopsy approaches, while emphasizing reproducibility, turnaround time, quality assurance, and compatibility with existing platforms. Companion-diagnostic alignment, decentralized testing, and clearer interpretation of complex variant results are becoming increasingly important as oncology care moves toward more individualized treatment pathways.

Artificial Intelligence Strengthens Interpretation and Workflow Efficiency

Artificial intelligence can improve this field by supporting image and signal interpretation, flagging quality-control anomalies, prioritizing variants, and helping laboratories manage workflow data. Its value depends on representative validation datasets, transparent performance measures, human oversight, cybersecurity, and compliance with applicable medical-device requirements. AI should augment-not replace-laboratory professionals, particularly when results are technically ambiguous or have significant treatment implications.

Regional Insights Across Global Diagnostic Systems

North America generally benefits from advanced molecular laboratories, established oncology networks, and structured biomarker testing pathways, although access and reimbursement can vary by jurisdiction. Europe combines strong research capacity with diverse national regulatory and funding environments. Asia-Pacific includes sophisticated testing ecosystems alongside rapidly expanding access needs, with infrastructure and workforce differences across markets. Latin America continues to face uneven availability of specialized testing and relies on referral networks in many settings. The Middle East is developing centralized and hospital-based molecular capabilities, while Africa’s implementation is influenced by laboratory infrastructure, financing, specimen logistics, and specialist availability.

Group Insights Reveal Different Policy and Access Priorities

ASEAN economies show varied laboratory maturity and benefit from regional cooperation, shared training, and streamlined referral systems. BRICS members combine substantial scientific capabilities with pronounced differences in affordability, procurement, and geographic access. The European Union emphasizes harmonized quality, data governance, and cross-border diagnostic standards, while G7 systems generally prioritize evidence generation, interoperability, and clinical utility. GCC countries are investing in advanced healthcare infrastructure and centralized expertise. NATO members span diverse health systems, making resilient supply chains, common quality practices, and secure data exchange particularly relevant.

Country-Level Considerations for Implementation

Australia and Canada must address geographic dispersion and equitable access across centralized health services. Brazil, Mexico, and India face large and diverse patient populations, with referral capacity, affordability, and laboratory standardization remaining important considerations. China, Japan, and South Korea have strong clinical and research capabilities but differ in regulatory pathways, procurement structures, and adoption practices. France, Germany, Italy, Spain, and the United Kingdom operate within mature European oncology environments, with implementation influenced by national assessment, reimbursement, and laboratory governance. Russia’s diagnostic environment is shaped by domestic capacity, procurement conditions, and access to specialized technologies. In the United States, broad laboratory capability coexists with variation in payer coverage, testing pathways, and clinical-site practices.

Action Priorities for Leaders in Molecular Diagnostics

Industry leaders should validate assays across relevant specimen types and clinically important variants, document analytical performance transparently, and design workflows that minimize tissue consumption and repeat testing. They should build partnerships with oncology networks and reference laboratories, invest in proficiency testing and workforce development, and prepare evidence that demonstrates clinical utility rather than technical performance alone. Regional strategies should account for regulatory differences, reimbursement realities, supply continuity, data protection, and equitable access. AI-enabled features should be introduced through controlled validation, monitoring, and clear accountability mechanisms.

Research Methodology for the Executive Summary

This executive summary uses the specified diagnostic category and required geographic groupings as its analytical scope. The assessment is structured around established considerations in molecular oncology diagnostics, including biomarker relevance, multiplex testing, laboratory workflow, regulatory oversight, reimbursement, infrastructure, quality management, and responsible AI use. Regional, group, and country observations are qualitative and comparative; no market estimates, shares, forecasts, or company-specific claims are included. Conclusions should be supplemented with current jurisdiction-level clinical guidelines, regulatory documents, reimbursement policies, and laboratory validation evidence before operational decisions are made.

Conclusion: Building Reliable, Equitable Biomarker Testing Pathways

Multiplex detection of EGFR, KRAS, BRAF, PIK3CA, ALK, and ROS1 alterations is an important component of precision oncology, but its impact depends on more than assay availability. Reliable implementation requires validated performance, integrated clinical workflows, skilled interpretation, sustainable quality systems, and equitable patient access. Organizations that combine technical rigor with regional adaptation and responsible use of artificial intelligence will be better positioned to support timely, clinically meaningful molecular decisions.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market, by Technology
7.1. Introduction
7.2. Digital Pcr
7.3. Next Gen Sequencing
7.3.1. Targeted Sequencing
7.3.2. Whole Exome Sequencing
7.3.3. Whole Genome Sequencing
7.4. Real Time Pcr
7.5. Sanger Sequencing
8. Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market, by Cancer Type
8.1. Introduction
8.2. Breast Cancer
8.3. Colorectal Cancer
8.4. Lung Cancer
8.5. Melanoma
9. Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market, by Sample Type
9.1. Introduction
9.2. Blood Plasma
9.3. Tissue
10. Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market, by Product Type
10.1. Introduction
10.2. Instruments
10.3. Reagent Kits
11. Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market, by End User
11.1. Introduction
11.2. Academic And Research Institutes
11.3. Diagnostic Laboratories
11.4. Hospitals And Clinics
12. Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Abbott Laboratories, Inc.
16.2. Agilent Technologies, Inc.
16.3. Amoy Diagnostics Co., Ltd.
16.4. Bio-Rad Laboratories, Inc.
16.5. Biocartis NV
16.6. bioMérieux SA
16.7. EntroGen, Inc.
16.8. Illumina, Inc.
16.9. Pillar Biosciences, Inc.
16.10. QIAGEN N.V.
16.11. Roche Holding AG
16.12. Sysmex Corporation
16.13. Thermo Fisher Scientific, Inc.
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market, Years Considered for the Study
FIGURE 2. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market, Research Design
FIGURE 3. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market, Research Framework
FIGURE 4. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market, Data Triangulation
FIGURE 5. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 7. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Cancer Type, 2025 vs 2032 (%)
FIGURE 9. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Cancer Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Sample Type, 2025 vs 2032 (%)
FIGURE 11. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Sample Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 13. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Segmentation & Coverage
TABLE 2. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, 2017-2032 (USD Million)
TABLE 3. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 4. Global Digital Pcr Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Digital Pcr Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Digital Pcr Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Next Gen Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Next Gen Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Next Gen Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Targeted Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Targeted Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Targeted Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Whole Exome Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Whole Exome Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Whole Exome Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Whole Genome Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Whole Genome Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Whole Genome Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Real Time Pcr Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Real Time Pcr Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Real Time Pcr Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Sanger Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Sanger Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Sanger Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Cancer Type, 2017-2032 (USD Million)
TABLE 26. Global Breast Cancer Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Breast Cancer Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Breast Cancer Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Colorectal Cancer Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Colorectal Cancer Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Colorectal Cancer Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Lung Cancer Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Lung Cancer Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Lung Cancer Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Melanoma Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Melanoma Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Melanoma Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 39. Global Blood Plasma Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Blood Plasma Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Blood Plasma Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Tissue Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global Tissue Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global Tissue Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 46. Global Instruments Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Instruments Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Instruments Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Reagent Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Reagent Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Reagent Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 53. Global Academic And Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Academic And Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Academic And Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Diagnostic Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Diagnostic Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Diagnostic Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Hospitals And Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Hospitals And Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Hospitals And Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Asia-Pacific Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Asia-Pacific Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 65. Asia-Pacific Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Next Gen Sequencing, 2017-2032 (USD Million)
TABLE 66. Asia-Pacific Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Cancer Type, 2017-2032 (USD Million)
TABLE 67. Asia-Pacific Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 68. Asia-Pacific Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 69. Asia-Pacific Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 70. North America Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. North America Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 72. North America Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Next Gen Sequencing, 2017-2032 (USD Million)
TABLE 73. North America Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Cancer Type, 2017-2032 (USD Million)
TABLE 74. North America Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 75. North America Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 76. North America Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 77. Latin America Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Latin America Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 79. Latin America Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Next Gen Sequencing, 2017-2032 (USD Million)
TABLE 80. Latin America Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Cancer Type, 2017-2032 (USD Million)
TABLE 81. Latin America Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 82. Latin America Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 83. Latin America Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 84. Europe Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Europe Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 86. Europe Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Next Gen Sequencing, 2017-2032 (USD Million)
TABLE 87. Europe Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Cancer Type, 2017-2032 (USD Million)
TABLE 88. Europe Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 89. Europe Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 90. Europe Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 91. Middle East Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Region, 2017-2032 (USD Million)
TABLE 92. Middle East Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 93. Middle East Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Next Gen Sequencing, 2017-2032 (USD Million)
TABLE 94. Middle East Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Cancer Type, 2017-2032 (USD Million)
TABLE 95. Middle East Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 96. Middle East Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 97. Middle East Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 98. Africa Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Region, 2017-2032 (USD Million)
TABLE 99. Africa Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 100. Africa Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Next Gen Sequencing, 2017-2032 (USD Million)
TABLE 101. Africa Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Cancer Type, 2017-2032 (USD Million)
TABLE 102. Africa Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 103. Africa Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 104. Africa Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 105. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Group, 2017-2032 (USD Million)
TABLE 106. ASEAN Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Group, 2017-2032 (USD Million)
TABLE 107. ASEAN Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 108. ASEAN Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Next Gen Sequencing, 2017-2032 (USD Million)
TABLE 109. ASEAN Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Cancer Type, 2017-2032 (USD Million)
TABLE 110. ASEAN Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 111. ASEAN Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 112. ASEAN Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 113. GCC Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Group, 2017-2032 (USD Million)
TABLE 114. GCC Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 115. GCC Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Next Gen Sequencing, 2017-2032 (USD Million)
TABLE 116. GCC Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Cancer Type, 2017-2032 (USD Million)
TABLE 117. GCC Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 118. GCC Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 119. GCC Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 120. European Union Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Group, 2017-2032 (USD Million)
TABLE 121. European Union Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 122. European Union Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Next Gen Sequencing, 2017-2032 (USD Million)
TABLE 123. European Union Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Cancer Type, 2017-2032 (USD Million)
TABLE 124. European Union Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 125. European Union Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 126. European Union Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 127. BRICS Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Group, 2017-2032 (USD Million)
TABLE 128. BRICS Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 129. BRICS Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Next Gen Sequencing, 2017-2032 (USD Million)
TABLE 130. BRICS Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Cancer Type, 2017-2032 (USD Million)
TABLE 131. BRICS Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 132. BRICS Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 133. BRICS Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 134. G7 Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Group, 2017-2032 (USD Million)
TABLE 135. G7 Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 136. G7 Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Next Gen Sequencing, 2017-2032 (USD Million)
TABLE 137. G7 Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Cancer Type, 2017-2032 (USD Million)
TABLE 138. G7 Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 139. G7 Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 140. G7 Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 141. NATO Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Group, 2017-2032 (USD Million)
TABLE 142. NATO Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 143. NATO Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Next Gen Sequencing, 2017-2032 (USD Million)
TABLE 144. NATO Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Cancer Type, 2017-2032 (USD Million)
TABLE 145. NATO Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 146. NATO Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 147. NATO Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 148. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Country, 2017-2032 (USD Million)
TABLE 149. United States Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, 2017-2032 (USD Million)
TABLE 150. United States Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 151. United States Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Next Gen Sequencing, 2017-2032 (USD Million)
TABLE 152. United States Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Cancer Type, 2017-2032 (USD Million)
TABLE 153. United States Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 154. United States Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 155. United States Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 156. Canada Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, 2017-2032 (USD Million)
TABLE 157. Canada Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 158. Canada Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Next Gen Sequencing, 2017-2032 (USD Million)
TABLE 159. Canada Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Cancer Type, 2017-2032 (USD Million)
TABLE 160. Canada Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 161. Canada Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 162. Canada Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 163. Mexico Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, 2017-2032 (USD Million)
TABLE 164. Mexico Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 165. Mexico Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Next Gen Sequencing, 2017-2032 (USD Million)
TABLE 166. Mexico Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Cancer Type, 2017-2032 (USD Million)
TABLE 167. Mexico Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 168. Mexico Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 169. Mexico Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 170. Brazil Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, 2017-2032 (USD Million)
TABLE 171. Brazil Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 172. Brazil Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Next Gen Sequencing, 2017-2032 (USD Million)
TABLE 173. Brazil Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Cancer Type, 2017-2032 (USD Million)
TABLE 174. Brazil Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 175. Brazil Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 176. Brazil Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 177. United Kingdom Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, 2017-2032 (USD Million)
TABLE 178. United Kingdom Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 179. United Kingdom Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Next Gen Sequencing, 2017-2032 (USD Million)
TABLE 180. United Kingdom Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Cancer Type, 2017-2032 (USD Million)
TABLE 181. United Kingdom Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 182. United Kingdom Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 183. United Kingdom Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 184. Germany Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, 2017-2032 (USD Million)
TABLE 185. Germany Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 186. Germany Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Next Gen Sequencing, 2017-2032 (USD Million)
TABLE 187. Germany Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Cancer Type, 2017-2032 (USD Million)
TABLE 188. Germany Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 189. Germany Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 190. Germany Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 191. France Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, 2017-2032 (USD Million)
TABLE 192. France Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 193. France Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Next Gen Sequencing, 2017-2032 (USD Million)
TABLE 194. France Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Cancer Type, 2017-2032 (USD Million)
TABLE 195. France Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 196. France Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 197. France Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 198. Russia Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, 2017-2032 (USD Million)
TABLE 199. Russia Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 200. Russia Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Next Gen Sequencing, 2017-2032 (USD Million)
TABLE 201. Russia Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Cancer Type, 2017-2032 (USD Million)
TABLE 202. Russia Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 203. Russia Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 204. Russia Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 205. Italy Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, 2017-2032 (USD Million)
TABLE 206. Italy Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 207. Italy Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Next Gen Sequencing, 2017-2032 (USD Million)
TABLE 208. Italy Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Cancer Type, 2017-2032 (USD Million)
TABLE 209. Italy Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 210. Italy Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 211. Italy Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 212. Spain Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, 2017-2032 (USD Million)
TABLE 213. Spain Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 214. Spain Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Next Gen Sequencing, 2017-2032 (USD Million)
TABLE 215. Spain Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Cancer Type, 2017-2032 (USD Million)
TABLE 216. Spain Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 217. Spain Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 218. Spain Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 219. China Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, 2017-2032 (USD Million)
TABLE 220. China Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 221. China Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Next Gen Sequencing, 2017-2032 (USD Million)
TABLE 222. China Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Cancer Type, 2017-2032 (USD Million)
TABLE 223. China Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 224. China Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 225. China Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 226. India Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, 2017-2032 (USD Million)
TABLE 227. India Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 228. India Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Next Gen Sequencing, 2017-2032 (USD Million)
TABLE 229. India Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Cancer Type, 2017-2032 (USD Million)
TABLE 230. India Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 231. India Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 232. India Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 233. Japan Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, 2017-2032 (USD Million)
TABLE 234. Japan Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 235. Japan Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Next Gen Sequencing, 2017-2032 (USD Million)
TABLE 236. Japan Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Cancer Type, 2017-2032 (USD Million)
TABLE 237. Japan Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 238. Japan Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 239. Japan Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 240. Australia Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, 2017-2032 (USD Million)
TABLE 241. Australia Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 242. Australia Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Next Gen Sequencing, 2017-2032 (USD Million)
TABLE 243. Australia Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Cancer Type, 2017-2032 (USD Million)
TABLE 244. Australia Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 245. Australia Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 246. Australia Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 247. South Korea Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, 2017-2032 (USD Million)
TABLE 248. South Korea Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 249. South Korea Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Next Gen Sequencing, 2017-2032 (USD Million)
TABLE 250. South Korea Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Cancer Type, 2017-2032 (USD Million)
TABLE 251. South Korea Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 252. South Korea Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 253. South Korea Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 254. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Share, by Key Player, 2025
TABLE 255. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market, Key Experts

Companies Mentioned

  • Abbott Laboratories, Inc.
  • Agilent Technologies, Inc.
  • Amoy Diagnostics Co., Ltd.
  • Bio-Rad Laboratories, Inc.
  • Biocartis NV
  • bioMérieux SA
  • EntroGen, Inc.
  • Illumina, Inc.
  • Pillar Biosciences, Inc.
  • QIAGEN N.V.
  • Roche Holding AG
  • Sysmex Corporation
  • Thermo Fisher Scientific, Inc.

Related Topics

Related Reports

Human EGFR Gene Mutation Detection Kit Market - Global Forecast 2026-2032 - Product Image

Human EGFR Gene Mutation Detection Kit Market - Global Forecast 2026-2032

  • Report
  • 183 Pages
  • Global
From
EGFR Companion Diagnostics Market - Strategic Insights and Forecasts (2026-2035) - Product Image

EGFR Companion Diagnostics Market - Strategic Insights and Forecasts (2026-2035)

  • Report
  • 176 Pages
  • Global
From
EGFR Tests Market - Global Forecast 2026-2032 - Product Image

EGFR Tests Market - Global Forecast 2026-2032

  • Report
  • 182 Pages
  • Global
From
EGFR Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2036 - Product Image

EGFR Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2036

  • Report
  • Global
From
Global Companion Diagnostics (CDx) Market - Competitive Landscape Analysis, 2026 - Product Image

Global Companion Diagnostics (CDx) Market - Competitive Landscape Analysis, 2026

  • Report
  • 185 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.